GlassScriptPhysician profile
Amit Guttigoli
NPI 1760417026
$15,495.32
in general payments reported to CMS, 2019-2025
45 companies · $3,518 in 2025
The $3,518 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,955 · 2020: $1,025 · 2021: $1,747 · 2022: $1,737 · 2023: $2,279 · 2024: $2,234 · 2025: $3,518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,022 · Travel and Lodging: $9.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,022.14 |
| Travel and Lodging | $9.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,321.25 | 2019-2025 | Farapulse, Lux-Dx Insertable Cardiac Monitor, Rhythmia Mapping System |
| Abbott Laboratories | $1,710.15 | 2019-2025 | Aveir, Ensite, Gallant |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,342.45 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $1,029.67 | 2019-2020 | |
| Medtronic, INC. | $949.70 | 2021-2025 | Corevalve Evolut R, Na |
| Biotronik INC. | $539.61 | 2019-2025 | Orsiro Mission, Biomonitor |
| Janssen Pharmaceuticals, INC | $427.44 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $291.53 | 2020-2023 | Farxiga |
| Cardiva Medical, INC. | $284.36 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Merck Sharp & Dohme LLC | $278.37 | 2022-2025 | Verquvo |
| Cvrx, INC. | $268.13 | 2024-2025 | Barostim Neo System |
| Pfizer INC. | $254.16 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $242.64 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $232.88 | 2019-2023 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $217.67 | 2024-2025 | Assure Wcd |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $208.11 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $200.25 | 2023 | Optimizer |
| Philips North America LLC | $151.73 | 2020-2025 | Event, (Ck4) Mcot, (Ck7) Extended Holter |
| Aop Health US, LLC | $150.14 | 2025 | Rapiblyk |
| Ebr Systems, INC. | $128.54 | 2025 | |
| Biosense Webster, INC. | $108.05 | 2023-2025 | Carto 3 |
| Amarin Pharma, INC. | $103.03 | 2019-2020 | |
| Amgen INC. | $96.14 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $96.09 | 2023-2024 | Inpefa |
| Edwards Lifesciences Corporation | $89.02 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $81.49 | 2022-2025 | |
| Ethicon US, LLC | $79.95 | 2025 | Vistaseal |
| Sanofi-Aventis U.S. LLC | $79.91 | 2019-2024 | |
| Siemens Medical Solutions USA, INC. | $61.45 | 2023-2024 | Biograph Horizon-3r |
| Atricure, INC. | $61.29 | 2022-2024 | |
| Astellas Pharma US INC | $58.33 | 2019-2020 | |
| Vital Connect, INC | $52.98 | 2025 | Vitalpatch Rtm |
| Inspire Medical Systems, INC. | $44.55 | 2024-2025 | Inspire |
| Lantheus Medical Imaging, INC. | $38.22 | 2019 | |
| Tactile Systems Technology INC | $33.07 | 2019-2023 | Flexitouch Plus, Entre Plus |
| Kiniksa Pharmaceuticals, LTD. | $25.48 | 2022 | |
| Cardiovascular Systems INC. | $23.31 | 2021 | |
| Itamar Medical INC | $19.72 | 2024 | Watchpatone |
| Altathera Pharmaceuticals LLC | $19.17 | 2025 | Sotalol Hydrochloride |
| Glaxosmithkline, LLC. | $18.48 | 2025 | Arexvy, Shingrix |
| Actelion Pharmaceuticals US, INC. | $18.46 | 2024 | Uptravi, Opsumit |
| Convatec INC. | $18.46 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.31 | 2019 | |
| Chiesi USA, INC. | $14.10 | 2022 | |
| Angiodynamics, INC. | $11.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Guttigoli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.